In 2019, the MEDICIS Project will be supported by the ProTechno Foundation. Thanks to their generous donation to the CERN & Society Foundation, we can help to support the Project’s further development, notably in the area of hardware acquisition and running costs.
CERN–MEDICIS (Medical Isotopes Collected from ISOLDE) is a unique facility, designed to produce radioisotopes with the right properties to enhance the precision of both patient imaging and treatment, thereby providing the opportunity to radically improve the success of cancer treatments. The Project aims to expand the range of radioisotopes available for medical research – some of which can only be produced at CERN – and send them to hospitals and research centres in Switzerland and across Europe for further study.
Initiated in 2010 by CERN, MEDICIS is driven by CERN’s Isotope Mass Separator Online (ISOLDE) facility. ISOLDE has been running for 50 years, and 1300 different isotopes from 73 chemicals have already been produced at CERN for research in many areas, including fundamental nuclear research. In 2018, MEDICIS produced a new isotope (Terbium 155Tb) which is considered a promising radioisotope for diagnosing prostate cancer, as early results have shown. Many more are yet to be discovered and tested.
The production of new isotopes is ongoing, and the valuable support from the ProTechno Foundation will undoubtedly contribute towards MEDICIS playing an important role in the fight against cancer.
MEDICIS is a CERN & Society project supported by external voluntary funding. To learn more about CERN & Society activities and how you can be involved, visit the dedicated webpage.